消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 BSG/ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）

2021-08-02 英国胃肠病学会 Gut.2021 Sep;70(9):1611-1628.

抗血小板内镜检查

2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查指南。该指南是对2016年版指南的更新，指南对内镜手术的风险类别和血栓形成风险类别进行

中文标题：

2021 BSG/ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）

英文标题：

Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update

发布机构：

英国胃肠病学会

发布日期：

2021-08-02

简要介绍：

2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查指南。该指南是对2016年版指南的更新，指南对内镜手术的风险类别和血栓形成风险类别进行修订，增加了关于急性胃肠道出血患者的管理内容并强调了重要换值得注意事项。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 BSG_ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=546151c00215a4db, title=2021 BSG/ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）, enTitle=Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update, guiderFrom=Gut.2021 Sep;70(9):1611-1628., authorId=0, author=, summary=2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查指南。该指南是对2016年版指南的更新，指南对内镜手术的风险类别和血栓形成风险类别进行, cover=https://img.medsci.cn/2021815/1629013535422_2020535.jpg, journalId=0, articlesId=null, associationId=265, associationName=英国胃肠病学会, associationIntro=英国胃肠病学会（The British Society of Gastroenterology，BSG）专注于提升英国胃肠病学医疗水平，其涉及内科、外科、病理、放射、科学、护理、营养等领域。指南可以按日期、及专科浏览。, copyright=0, guiderPublishedTime=Mon Aug 02 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年，英国胃肠病学会(BSG)联合欧洲胃肠道内窥镜学会(ESGE)更新发布了抗血小板或抗凝治疗患者的内镜检查指南。该指南是对2016年版指南的更新，指南对内镜手术的风险类别和血栓形成风险类别进行修订，增加了关于急性胃肠道出血患者的管理内容并强调了重要换值得注意事项。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=836, tagName=抗血小板), TagDto(tagId=5096, tagName=内镜检查)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=5096, guiderKeyword=内镜检查, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5608, appHits=171, showAppHits=0, pcHits=813, showPcHits=5436, likes=2, shares=13, comments=6, approvalStatus=1, publishedTime=Sun Aug 15 16:06:33 CST 2021, publishedTimeString=2021-08-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 15 15:45:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:21:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 BSG_ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）.pdf)])
2021 BSG_ESGE指南：抗血小板或抗凝治疗患者的内镜检查（更新版）.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2022-11-18 ms5000001165770558

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-10-21 NeilAspx

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-10-04 ms6000000298623125

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2101258, encodeId=17162101258e9, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3ed6471375, createdName=ms5000001165770558, createdTime=Fri Nov 18 08:58:51 CST 2022, time=2022-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082361, encodeId=936510823615f, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:42:09 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062548, encodeId=c7661062548bb, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEK3TQvnP74Q2JsVzgN9iaWLvcGH4vNg9piaLqpW8m88yk4ict5xcf4LAOyGq6Oicy410VykSdsOmT8uhg/132, createdBy=766e2511801, createdName=NeilAspx, createdTime=Thu Oct 21 11:40:50 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057617, encodeId=ee88105e61720, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a155600872, createdName=ms6000000298623125, createdTime=Mon Oct 04 16:22:21 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008813, encodeId=94ce1008813fc, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/79787990fd4d410da13321cd9d24e82e/1a10fd45711f4729a717d387ae168480.jpg, createdBy=9f355541150, createdName=变ms2000001668246797, createdTime=Tue Aug 17 20:12:10 CST 2021, time=2021-08-17, status=1, ipAttribution=)]
    2021-08-17 变ms2000001668246797

    厉害

    0

相关指南

氯吡格雷/阿司匹林单片复方制剂抗血小板治疗中国专家共识

中国医师协会心血管内科医师分会(CCCP,Chinese College of Cardiovascular Physicians) · 2021-06-30

2017 ASRA/ESRA/AAPM/INS/NANS/WIP指南:服用抗血小板和抗凝药物患者进行脊柱和疼痛介入治疗(第2版)

美国区域麻醉和疼痛医学学会(ASRA,American Society of Regional Anesthesia and Pain Medicine) · 2017-12-22

2014 抗血小板药物治疗反应多样性临床检测和处理的中国专家建议

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2014-12-20

2014 WHF专家共识声明：东亚ACS或接受PCI治疗患者的抗血小板治疗

世界心脏病联盟(WHF,World Heart Federation) · 2014-08-26

短暂性脑缺血发作与轻型卒中抗血小板治疗中国专家共识（2014年）

短暂性脑缺血发作中国专家共识组 · 2014-07-15

2013 抗血小板治疗中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2013-03-15

拓展阅读

2016 ASGE指南：内镜检查在胰腺囊性肿瘤的诊断和治疗中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-05-17

2016 ASGE指南：内镜检查在炎性胰腺液体积聚诊治中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2016-01-12

2015 ASGE指南：内镜检查在壶腹周围和十二指肠腺瘤中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-08-07

2015 ASGE指南：内镜检查在良性胰腺疾病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-07-12

2015 ASGE指南：内镜检查在消化不良中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-05-29

2015 ASGE指南：内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20